Portfolio Lab

Core Scientific, Inc./tx

  • Stock
  • Ticker CORZ
  • ISIN US21874A1060
  • Nasdaq

Financials · Consumer finance and lenders · USA

$11.33 −15.19%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Core Scientific, Inc./tx since 01/2024, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

CORZGlobal equities (VT)

$10,000 grew to $32,936. Global equities (VT): $14,453.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −64.9% in 04/2025, measured from the peak in 11/2024. It took 11 months to get back to the old peak.

1-year return
−25.3%
Return p.a. since 01/2024
+52.5%
Volatility p.a.
99.3%
Largest decline
−64.9%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue9580798180115164233
Gross profit4.88.25.03.9213070123
Operating income-65-47-26-55-117-310-7872
EBITDA-39-27-7.7-39-103-294-6390
Net income-291576-937-144216-347-1,1551,178
Earnings per share-0.691.24-0.04-0.450.60-1.06-3.320.47
Balance sheet
Total assets1,4761,4981,8512,1712,3483,0705,2575,936
Liabilities2,4191,8073,0433,4243,3104,3757,6777,028
Equity-943-309-1,192-1,253-963-1,306-2,419-1,092
Cash8366985814533111,0051,770804
Long-term debt––––1,0601,0624,2984,302
Cash flow
Operating cash flow14-4534132158250-1965
Capital expenditure-29-84-121-244-279-389-565-541
Free cash flow-15-129-87-113-122-139-584-475

Value it:DCF calculatorMultiples calculator

Annual returns

* partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$0.47
28 Jul 2026−$3.32
6 May 2026−$1.06
2 Mar 2026$0.60
24 Oct 2025−$0.45
8 Aug 2025−$0.04
7 May 2025$1.24
27 Feb 2025−$0.69
6 Nov 2024−$1.17
7 Aug 2024−$5.05
9 May 2024$0.78
13 Mar 2024−$0.52

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€3.3bn
Market cap in trading currency
$3.65bn
Enterprise value
–
P/E
–
P/S
6.17
P/B
–
EV/Sales
–
EV/EBITDA
–
Earnings yield
–
FCF yield
–

Results (last four quarters)

Revenue
$592m
Gross profit
$244m
EBITDA
–
Net income
−$108m
Earnings per share
−$3.31
Revenue per share
$1.84
Revenue growth
+187.1%
Earnings growth
–

Profitability

Gross margin
41.2%
Operating margin
-35.9%
Net margin
-18.3%
Return on equity
–
Return on assets
-1.8%

Balance sheet and cash flow

Cash
$804m
Cash per share
$2.49
Financial debt
–
Debt/equity %
–
Current ratio
–
Book value per share
−$3.39
Operating cash flow
–
Free cash flow
–

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
322m
Volume
22.2m
Avg. volume 3 months
14.2m
Relative volume
1.5

Price and technicals

Price
$11.33
1 day
−15.2%
52-week high
$29.16
52-week low
$11.33
Distance to 52-week high
−61.1%
Distance to 52-week low
0.0%
Distance to 50-day line
−24.0%
Distance to 200-day line
−41.2%
RSI (14)
38
Volatility 1M
120.2%

Performance

1 week
−22.0%
1 month
−14.2%
3 months
−34.4%
6 months
−55.1%
YTD
−22.2%
1 year
−26.4%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has CORZ performed since 01/2024?

$10,000 grew to $32,936 by 20 Nov 2026, which is +52.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is CORZ?

Volatility was 99.3% per year, measured on monthly returns. The largest decline from a peak was −64.9%, with the low in 04/2025.

How does CORZ compare with a broad equity ETF?

Over the same period Global equities (VT) returned +13.9% per year at 12.3% volatility, CORZ returned +52.5% at 99.3%. The correlation of monthly returns was 0.57; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Core Scientific, Inc./tx (CORZ): Return and risk